60
Views
8
CrossRef citations to date
0
Altmetric
Original

The Importance of Parity to Major Maternal Morbidity in the Eclamptic Mother with Hellp Syndrome

, M.D., , M.D., , M.D., , Ph.D., , M.D. & , M.D.
Pages 287-294 | Published online: 07 Jul 2009

References

  • The American College of Obstetricians and Gynecologists M. Hypertension in pregnancy. American College of Obstetricians and Gynecologists, Washington, DC 1996
  • Caritis S, Sibai B, Hauth J, Lindheimer M, VanDorsten P, Klebanoff M, et al. Predictors of pre‐eclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal‐Fetal Medicine Units. Am J Obstet Gynecol 1998; 179: 946–951
  • Porapakkham S. An epidemiologic study of eclampsia. Obstet Gynecol 1979; 54: 26–30
  • Sibai B M, Taslimi M M, el‐Nazer A, Amon E, Mabie B C, Ryan G M. Maternal‐perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia–eclampsia. Am J Obstet Gynecol 1986; 155: 501–509
  • Long P A, Abell D A, Beischer N A. Parity and pre‐eclampsia. Aust N Z J Obstet Gynaecol 1979; 19: 203–206
  • Martin J N, Jr, Magann E F, May W L, Rinehart B K, Terrone D A, Blake P G. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome classification. Am J Obstet Gynecol 1999; 180: 1373–1384
  • Martin J N, Jr, May W L, Magann E F, Terrone D A, Rinehart B K, Blake P G. Early risk assessment of severe preeclampsia (ERASP): admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 1999; 180: 1407–1414
  • Conde‐Agudelo A, Kafury‐Goeta A C. Case‐control study of risk factors for complicated eclampsia. Obstet Gynecol 1997; 90: 172–175
  • Lindheimer M D, Roberts J M, et al. Chesley's Hypertensive Disorders in Pregnancy2nd Ed. Appleton and Lange, Stamford, CT 1999; 29
  • Trupin L S, Simon L P, Eskenazi B. Change in paternity: a risk factor for preeclampsia in multiparas. Epidemiology 1996; 7: 240–244
  • Gunnlaugsson S R, Geirsson R T, Snaedal G, Hallgrimsson J T. Incidence and relation to parity of pregnancy‐induced hypertension in Iceland. Acta Obstet Gynecol Scand 1989; 68(7)599–601
  • Parazzini F, Bortolus R, Chatenoud L, Restelli S, Ricci E, Marozio L, et al. Risk factors for pregnancy‐induced hypertension in women at high risk for the condition. Italian Study of Aspirin in Pregnancy Group. Epidemiology 1996; 7: 306–308
  • Bobrowski R A, Bottoms S F. Underappreciated risks of the elderly multipara. Am J Obstet Gynecol 1995; 172: 1764–1767
  • Mittendorf R, Lain K Y, Williams M A, Walker C K. Preeclampsia. A nested, case‐control study of risk factors and their interactions. J Reprod Med 1996; 41: 491–496
  • Sibai B M, Gordon T, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal‐Fetal Medicine Units. Am J Obstet Gynecol 1995; 172: 642–648
  • Martin J N, Jr, Perry K G, Jr, Miles J F, Jr, Blake P G, Magann E F, Roberts W E, et al. The interrelationship of eclampsia, HELLP syndrome and prematurity: cofactors for significant maternal and perinatal risk. Br J Obstet Gynaecol 1993; 100: 1095–1100

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.